Lam Research falls 3.4% as chip-equipment stocks retreat after ASML update

Lam Research (LRCX) is down 3.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The move looks primarily sector-driven, with semiconductor equipment stocks pressured after ASML’s quarterly update appeared to disappoint investors on near-term profitability and policy risk even as AI-related demand remains intact. With Lam’s business tied to wafer-fab spending and global export rules, traders may also be de-risking ahead of Lam’s upcoming earnings event.

Details:

ASML reported Q1 2026 results and lifted its 2026 sales outlook, but market focus shifted to softer margin expectations and ongoing export-control uncertainty, which weighed on chip-equipment sentiment.

ASML commentary highlighted that geopolitical and trade-policy constraints can still affect how demand converts into shipments, a concern that often spills over to U.S. toolmakers like Lam.

U.S. lawmakers recently proposed additional restrictions on exporting/servicing certain semiconductor manufacturing tools to leading Chinese firms, an overhang for equipment suppliers with meaningful China exposure.

Lam is scheduled to host its quarterly financial conference call on April 22, 2026, which can amplify near-term positioning and volatility in the days leading up to the report.

Sources:

Lam Research Newsroom, Techzine, Tom’s Hardware, Quiver Quantitative

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$LRCX Insider Trading Activity

$LRCX insiders have traded $LRCX stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $LRCX stock by insiders over the last 6 months:

TIMOTHY ARCHER (President and CEO) has made 0 purchases and 2 sales selling 163,300 shares for an estimated $26,758,338.
DOUGLAS R BETTINGER (Chief Financial Officer & EVP) has made 0 purchases and 3 sales selling 130,466 shares for an estimated $26,534,860.
ERIC BRANDT has made 0 purchases and 2 sales selling 35,000 shares for an estimated $7,896,150.
AVA HARTER (Chief Legal Officer) has made 0 purchases and 4 sales selling 14,510 shares for an estimated $2,682,764.
BETHANY MAYER has made 0 purchases and 2 sales selling 1,328 shares for an estimated $212,452.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$LRCX Hedge Fund Activity

We have seen 1,061 institutional investors add shares of $LRCX stock to their portfolio, and 1,017 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 38,239,309 shares (-75.0%) from their portfolio in Q4 2025, for an estimated $6,545,804,914
PRICE T ROWE ASSOCIATES INC /MD/ added 10,666,540 shares (+352.2%) to their portfolio in Q4 2025, for an estimated $1,825,898,317
BLACKROCK, INC. added 10,000,727 shares (+8.0%) to their portfolio in Q4 2025, for an estimated $1,711,924,447
JPMORGAN CHASE & CO removed 6,436,253 shares (-21.5%) from their portfolio in Q4 2025, for an estimated $1,101,757,788
NORDEA INVESTMENT MANAGEMENT AB removed 3,909,309 shares (-34.6%) from their portfolio in Q4 2025, for an estimated $669,195,514
FRANKLIN RESOURCES INC added 3,671,073 shares (+57.0%) to their portfolio in Q4 2025, for an estimated $628,414,276
CORIENT PRIVATE WEALTH LLC added 3,649,553 shares (+235.5%) to their portfolio in Q4 2025, for an estimated $624,730,482

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$LRCX Congressional Stock Trading

Members of Congress have traded $LRCX stock 9 times in the past 6 months. Of those trades, 3 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $LRCX stock by members of Congress over the last 6 months:

REPRESENTATIVE DAVID TAYLOR has traded it 6 times. They made 1 purchase worth up to $15,000 on 03/12 and 5 sales worth up to $145,000 on 02/26, 01/16, 01/08.
REPRESENTATIVE CLEO FIELDS purchased up to $50,000 on 02/03.
SENATOR JOHN BOOZMAN sold up to $15,000 on 01/08.
SENATOR MARKWAYNE MULLIN purchased up to $100,000 on 12/29.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$LRCX Analyst Ratings

Wall Street analysts have issued reports on $LRCX in the last several months. We have seen 12 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Needham issued a "Buy" rating on 01/29/2026
Goldman Sachs issued a "Buy" rating on 01/29/2026
RBC Capital issued a "Outperform" rating on 01/15/2026
Wells Fargo issued a "Overweight" rating on 01/15/2026
Bernstein issued a "Outperform" rating on 01/12/2026
Mizuho issued a "Outperform" rating on 01/09/2026
B. Riley Securities issued a "Buy" rating on 12/18/2025

To track analyst ratings and price targets for $LRCX, check out Quiver Quantitative's $LRCX forecast page.

$LRCX Price Targets

Multiple analysts have issued price targets for $LRCX recently. We have seen 21 analysts offer price targets for $LRCX in the last 6 months, with a median target of $262.0.

Here are some recent targets:

Mehdi Hosseini from Susquehanna set a target price of $350.0 on 04/09/2026
Joseph Moore from Morgan Stanley set a target price of $260.0 on 04/06/2026
Tom O'Malley from Barclays set a target price of $255.0 on 03/10/2026
Atif Malik from Citigroup set a target price of $300.0 on 01/29/2026
Charles Shi from Needham set a target price of $300.0 on 01/29/2026
C.J. Muse from Cantor Fitzgerald set a target price of $320.0 on 01/29/2026
Mark Lipacis from Evercore ISI Group set a target price of $275.0 on 01/29/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.